Navigation Links
XYOTAX in Medical News

Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results

...operating expenses in 2008, by focusing resources on reaching $15 million in net Zevalin revenues, pursuing European marketing authorization (MAA) for xyotax (paclitaxel poliglumex, CT-2103), preparing for a potential U.S. marketing application (NDA) for pixantrone (BBR 2778) in 2009, and supporting the adv...

Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009

...tates and preparing the marketing applications for xyotax (paclitaxel poliglumex, CT-2103) and pixantrone (B... some phase III clinical trials for pixantrone and xyotax until planned regulatory filings and the completio...uct approvals. CTI expects to file for approval of xyotax in Europe in March. The Company will expand its co...

Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline

... O'Byrne, M.D., presented the phase III results of xyotax in first-line treatment of non-small cell lung can...." Dr. O'Byrne also presented data suggesting that xyotax may be particularly effective in women with pre-me...ate. Based on preclinical studies, it appears that xyotax is preferentially distributed to tumors due to the...

Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results

...ion of ZEVALIN, coupled with progress on advancing xyotax toward a first half 2008 marketing application sub... phase III clinical trials, PGT307 and PIX303, for xyotax and pixantrone (BBR 2778), respectively. Including...pared to currently marketed anthracyclines. About xyotax XYOTAX(TM) (paclitaxel poliglumex) is a biologica...

Multiple deaths forces cancer trial to be called off

...d in a big way with enrollment made at 170 medical centers globally last April, and had planned to study about 600 patients to prove the efficacy of xyotax in increasing the life span of patients with lung cancer using a regularly used chemotherapy agent coupled with a polymer which is supposed to help in...

Experimental Drug Reduces Tumor Size When Given With Radiation

... An experimental drug xyotax was successful in shrinking stomach and esophagus tumors in four out of 12 cancer patients, according to its maker Cell Therapeutics.// The other pati...
XYOTAX in Medical Technology

European Regulatory Agency Accepts Cell Therapeutics, Inc.'s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review

... beginning of March. The validation of the MAA for xyotax initiates the marketing approval review process, w...of the MAA. In the STELLAR 4 trial, single-agent xyotax resulted in comparable survival to gemcitabine or ...tor support. In addition to improved tolerability, xyotax offered more convenient administration compared to...

Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)

... xyotax to be reviewed for PS2 first-line non-small cell l...LAR trials. In the STELLAR 4 trial, single-agent xyotax resulted in comparable survival to gemcitabine or ...tor support. In addition to improved tolerability, xyotax offered more convenient administration compared to...

Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill

...atment for lung cancer. Data collected from recent xyotax trials suggests that estrogen levels may alter the...they respond differently to treatment. Through our xyotax studies, we continue to explore ways to turn a neg...ate. Based on preclinical studies, it appears that xyotax is preferentially distributed to tumors due to the...

Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill

...atment for lung cancer. Data collected from recent xyotax trials suggests that estrogen levels may alter the...they respond differently to treatment. Through our xyotax studies, we continue to explore ways to turn a neg...ate. Based on preclinical studies, it appears that xyotax is preferentially distributed to tumors due to the...

XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer

...source utilization (MRU) and associated costs with xyotax (paclitaxel polyglumex) treatment compared to gemc... average treatment cost, excluding drug costs, for xyotax patients was nearly half the cost of treatment for...tional, randomized trial (STELLAR 4) that compared xyotax (n=191) to gemcitabine or vinorelbine (n=190) in p...
XYOTAX in Biological Technology

Veteran Drug Industry Executive to Become President of CTI

...ation for FDA approval in late 2008 or early 2009. xyotax is also being studied independently in a phase III... negotiate an exclusive license for pixantrone. If xyotax receives regulatory approval in the U.S. or Europe...ir intended uses, a determination by the EMEA that xyotax should not be approved for sale in Europe, other d...

Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008

...resources to the GOG212 trial, a clinical trial of xyotax in first-line maintenance ovarian cancer being per... in the second half of 2009. The clinical trial of xyotax in combination with carboplatin in women with pre-...for the Company is to focus resources on obtaining xyotax and pixantrone approval with existing or completin...

Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule

...he STELLAR 4 phase III clinical trial results, for xyotax as a single agent for first-line treatment of non-...al The STELLAR 4 phase III clinical trial tested xyotax versus either gemcitabine or vinorelbine for the p...ate. Based on preclinical studies, it appears that xyotax is preferentially distributed to tumors due to the...

Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer

... significantly shorter than post-menopausal women. xyotax (TM) (paclitaxel poliglumex) will be studied in co...tion (MAA) in Europe in the first half of 2008 for xyotax as a single agent for first-line treatment of NSCL... 225 patients will be randomized to receive either xyotax 175mg/m2 plus carboplatin (AUC6) or paclitaxel 225...
Other Tags
(Date:9/17/2014)... Dallas, TX (PRWEB) September 17, 2014 ... they were recently granted several awards for their top-notch ... regarding patient experience, orthopedic care and GYN surgery. , ... Patient Safety Excellence Award™. They have received this award ... ranked among the top 5 percent in the nation ...
(Date:9/17/2014)... News, VA (PRWEB) September 17, 2014 ... will host recruit757’s scholarship workshop for football players ... on Tuesday, Sept. 23. , Doors open at 6:30 ... Performance Center and speak to trainers and physical therapists. ... until 9 p.m. , The Newport News Tidewater Performance ...
(Date:9/17/2014)... messages about the health benefits of quitting smoking may ... suggests. Although smokers who think quitting will be ... effects of smoking, researchers found smokers who believe they ... or positive, messages about how quitting will improve their ... of both types of messages might get more people ...
(Date:9/17/2014)... September 17, 2014 Prevention is the ... is hospitalizing scores of infants, children and teenagers in ... Kirk Mahon, medical director of Legacy ER & Urgent ... been no reported cases of EV-D68 so far in ... that could change,” he said. “Implementing prevention strategies now ...
(Date:9/17/2014)... 17, 2014 Boston Children’s Museum ... a monthly concert series, introducing young Museum visitors ... Top, America’s premier national platform celebrating the stories, ... of the young musicians featured will also be ... Children’s Museum is fortunate to partner with the ...
Breaking Medicine News(10 mins):Health News:North Central Surgical Center Receives Several Accolades 2Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 2Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 3Health News:More Than One Kind of Message May Convince Smokers to Quit, Study Says 2Health News:Legacy ER & Urgent Care Warns North Texans about Dangers of Enterovirus D68 2Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 2Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 3
(Date:9/16/2014)... on September 13, 2014. The fire is human-caused and ... 2,300 acres in size and is mostly being fueled ... calm Monday night due to higher humidity. Yesterday ... beginning to construct a fireline on the West and North ... on the fire: , 7 20-person Crews, 4 Hot Shot ...
(Date:9/16/2014)... of rock hit the Yukatan peninsula near the site of ... teratons of TNT. It left a crater more than 150 ... volcanism are widely accepted to have wiped out the dinosaurs ... what happened to the plants on which the dinosaurs fed? ... of Arizona reveals that the meteorite impact that spelled doom ...
(Date:9/16/2014)... votes for independence later this week, its Government could ... that fracking is necessary, research has revealed. , The ... public perception of shale gas extraction in the UK ... north of the border are the least supportive of ... in the University,s School of Geography, said: "The clear ...
Breaking Biology News(10 mins):Meteorite that doomed the dinosaurs helped the forests bloom 2Meteorite that doomed the dinosaurs helped the forests bloom 3Scottish people most sceptical on fracking, survey shows 2Scottish people most sceptical on fracking, survey shows 3
Other Contents